Related Experiment Video
Updated: Jun 10, 2026
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
[cDNA microarray technique on screening multi-drug resistance-related genes of human non-small cell lung cancer]
Meiyan Liu1, Chunhong Li, An Yan
1Department of Medical Oncology, Affiliated Tumor Hospital, Harbin Medical University, Harbin 150040, China.
Background And Objective:
The aim of this study is to screen for multi-drug resistance-related genes of human non-small cell lung cancer (NSCLC), and provide the evidences for drug-sensitive predicting genes of different NSCLC patients treated with chemotherapeutic drugs.
Methods:
Sensitivity and inhibition ratio of five antitumor drugs (NVB, GEM, TAL, DOC, CDDP) on 75 fresh NSCLC samples from different individuals were studied by means of culturing primary tumor cells and MTT assay. After the five chemotherapeutic drugs were used, multi-drug resistance-related genes of NSCLC with cDNA microarry on the samples which were all high sensitive and those resistant were screened.
Results:
cDNA microarray analysis screened out 212 genes, 168 of which were up-regulated while the other 44 were down-regulated in the group of highly sensitive compared with the group of resistance.
Conclusion:
The multi-drug resistance of NSCLC may be correlative with the 212 genes screened by cDNA microarray; the detailed mechanisms of the genes still need to be detected in the future.
Insights
Researchers identified 212 genes associated with multi-drug resistance in non-small cell lung cancer (NSCLC). This discovery aids in predicting drug sensitivity for personalized NSCLC chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Non-small cell lung cancer (NSCLC) presents significant challenges due to multi-drug resistance.
- Identifying predictive biomarkers for chemotherapy response is crucial for effective patient treatment.
Purpose:
- To screen for genes related to multi-drug resistance in NSCLC.
- To identify potential drug-sensitive predicting genes for personalized NSCLC chemotherapy.
Summary:
- This study utilized cDNA microarray analysis on 75 NSCLC samples treated with five chemotherapeutic drugs.
- The analysis identified 212 genes (168 up-regulated, 44 down-regulated) associated with drug sensitivity versus resistance.
Impact:
- The identified genes may serve as biomarkers for predicting NSCLC patient response to chemotherapy.
- This research provides a foundation for understanding NSCLC multi-drug resistance mechanisms and developing targeted therapies.
